Literature DB >> 26152294

Twenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term Disability.

Bruce C V Campbell1, Atte Meretoja2, Geoffrey A Donnan2, Stephen M Davis2.   

Abstract

Entities:  

Keywords:  Institute of Neurological Disorders and Stroke; National; cerebral infarction; computerized tomography; numbers need to treat; stroke; tissue-type plasminogen activator

Mesh:

Substances:

Year:  2015        PMID: 26152294     DOI: 10.1161/STROKEAHA.114.007564

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  27 in total

1.  Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia.

Authors:  Anja Kahl; Corey J Anderson; Liping Qian; Henning Voss; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-17       Impact factor: 6.200

2.  Two-kidney one-clip is a pertinent approach to integrate arterial hypertension in animal models of stroke: Serial magnetic resonance imaging studies of brain lesions before and during cerebral ischemia.

Authors:  Benjamin Ménard; Laurent Chazalviel; Simon Roussel; Myriam Bernaudin; Omar Touzani
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-15       Impact factor: 6.200

Review 3.  Hyperbaric oxygen therapy in acute stroke: is it time for Justitia to open her eyes?

Authors:  Milija D Mijajlovic; Vuk Aleksic; Nenad Milosevic; Natan M Bornstein
Journal:  Neurol Sci       Date:  2020-01-11       Impact factor: 3.307

Review 4.  Patients on NOACs in the Emergency Room.

Authors:  Stefan T Gerner; Hagen B Huttner
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-29       Impact factor: 5.081

5.  How Do Physicians Approach Intravenous Alteplase Treatment in Patients with Acute Ischemic Stroke Who Are Eligible for Intravenous Alteplase and Endovascular Therapy? Insights from UNMASK-EVT.

Authors:  J M Ospel; N Kashani; U Fischer; B K Menon; M Almekhlafi; A T Wilson; M M Foss; G Saposnik; M Goyal; M D Hill
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-23       Impact factor: 3.825

6.  Does the Addition of Non-Approved Inclusion and Exclusion Criteria for rtPA Impact Treatment Rates? Findings in Australia, the UK, and the USA.

Authors:  Louise E Craig; Sandy Middleton; Helen Hamilton; Fern Cudlip; Victoria Swatzell; Andrei V Alexandrov; Elizabeth Lightbody; Dame Caroline Watkins; Sheeba Philip; Dominique A Cadilhac; Elizabeth McInnes; Simeon Dale; Anne W Alexandrov
Journal:  Interv Neurol       Date:  2018-09-25

7.  Exogenous glutathione exerts a therapeutic effect in ischemic stroke rats by interacting with intrastriatal dopamine.

Authors:  He Wang; Yi-Sha Du; Wen-Shuo Xu; Chang-Jian Li; Hong Sun; Kang-Rui Hu; Yuan-Zhuo Hu; Teng-Jie Yu; Hui-Min Guo; Lin Xie; Guang-Ji Wang; Yan Liang
Journal:  Acta Pharmacol Sin       Date:  2021-05-25       Impact factor: 6.150

Review 8.  Four Decades of Ischemic Penumbra and Its Implication for Ischemic Stroke.

Authors:  Shao-Hua Yang; Ran Liu
Journal:  Transl Stroke Res       Date:  2021-07-05       Impact factor: 6.829

9.  Endothelial CD36 Contributes to Postischemic Brain Injury by Promoting Neutrophil Activation via CSF3.

Authors:  Lidia Garcia-Bonilla; Gianfranco Racchumi; Michelle Murphy; Josef Anrather; Costantino Iadecola
Journal:  J Neurosci       Date:  2015-11-04       Impact factor: 6.167

10.  A Clinical Observation of Intravenous Thrombolysis in Acute Ischemic Stroke with Minor Trauma.

Authors:  Yansen Cui; Liquan Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-17       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.